SIRNA AGAINST CBL-B AND OPTIONALLY IL2 UND IL12 FOR USE IN THE TREATMENT OF CANCER

摘要

The invention relates to a method for the immune activation of NK cells by the reduction or inhibition of the Cbl-b function in said cells. This stimulates the congenital immune system and thus permits the therapy of appropriate diseases.